Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

BioLineRx Ltd (BLRX)

NASDAQ
Currency in USD
Disclaimer
1.120
+0.010(+0.90%)
Closed
After Hours
1.100-0.020(-1.786%)

BLRX Comments

When is the fda approval?
BLRX long term range intervals looks like: 5-12-22-50-70-100+
BLRX should be back in force from May 20th...keep holding, keep accommodating and keep patience. Price below 3 will be a dream later! Research and approvals is a long-term process...
Any comments?
Should I buy now or wait for a dip?
I bought 1000 shares at 2,4 $ and hold 1,5 month and sold to invest to another stock. After that i bought again last week, its a buy but need a lot of patience. Every gap is closed now the 🚀 should start.
really? according to the patter for the past couple months it should go back down it looks like though
Im in - the time will show it is a good buy
Not much between here and $3.20s. After that $3.65 and above is blue sky.
🚀 pls start
https  :// w w w .reddit.com/r/WallStBets/comments/l723u6/blrx_bioline_rx_ltd/ (remove spacing between letters)
Is BioLineRx ADR (BLRX) Ready To Hit New Highs for 2021, good chances to cross $100 by EOY
I hold this one but there happening nothing :(
Hello Samir, it would be beautiful, but why $100 can you give an explanation¿?
BioLineRx Ltd., a clinical-stage biopharmaceutical focuses on oncology.Its development pipeline consists of clinical-stage therapeutic candidates, which include BL-8040 - Stem Cell mobilization completed Phase 3 and now waiting for regulatory approval, will be a great break thro.Other candidates sitting near by Phase 2, are:Pancreatic cancer *AMLAGI-134, an immuno-oncology agent in the development for solid tumors;and BL-5010, a customized, proprietary, pen-like applicator for the non-surgical removal of skin lesions. The above are the key upcoming Major Clinical Milestones in Next 10 Months.
🚀🚀🚀🚀
HC Wainwright Boost Price Target Buy $18.00 ➝ $22.00 High
that doesn't mean much
I hate this stock i hold it until december there is move up and 2 down
I bought in at 2.99. when do you guys think I'll see a large spike. Or did I make a bad move?
lol GL
You're good.
I bought in at 2.99. when do you guys think I'll see a large spike. Or did I make a bad move?
Nice
Wow...
buy this 4$ by march
Waiting for the big spike but when it will happen? Soon? Late¿
When the offering closes. Soon.
buy
🚀
Good entry point
stay long on this 10$ JUNE
PN, what do you think about POAI ?
Best buy 1.26 once it reaches
Perfect, got in today.
guys buy this will go up .Good opportunity to buy
I hate the ceo, why they do now a offering -.-
It would be a dream to have it pumped on good news to $100 like some other fraud companies. This company is a legit bio. When phase 3 trials are going on, you are close to more positive news releases Company has had reverse splits in the past which is a negative for holders who had it then. However:Announce good results.Announce funding collaborationAnnounce a deal with big drug company. Reverse split is not coming anytime soon again. So, hold it! IMHO realistic price target $ 20-30 this year with any of the above positives. Anything higher, take some of your profits and let the rest roll if you want.Just my IMHO. Been playing the Bio sector quite some time.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.